-
While some states are expecting a high-cost expansion population with complex needs in 2014, the Oklahoma Health Care Authority (OHCA), Oklahoma's Medicaid agency, expects its new enrollees may be fairly healthy. In addition, the state is seeing an uptick in revenue, which may mean that additional cuts to provider rates can be avoided.
-
While some Medicaid programs have taken steps to streamline the enrollment process in recent years, the "No Wrong Door" system required by health care reform is a very different challenge.
-
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
American non-Hispanic black persons had higher HbA1c levels than white persons at all levels of glycemia, and this difference increased as glucose intolerance worsened.
-
-
Since the publication of the allhat trial, clinicians have progressively relied upon diuretic-based regimens to manage hypertension (HTN).
-
Marine n-3 PUFAs act as pleiotropic agents on the cardiovascular system with a diverse range of effects most of which are beneficial for patients with known cardiovascular disease and possibly, they may even have beneficial effects with regard to the primary prevention of cardiovascular disease.
-
Lifetime surveillance is required after successful treatment of childhood cancers, since up to 75% of survivors develop serious complications and other late effects.
-
Dabigatran is indicated for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
-
Pulmonary function can help predict cardiovascular death risk in individuals in the intermediate-risk group of Framingham Risk Scores.